Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Safety and Efficacy of Salvage Therapy With Amprenavir, Lopinavir and Ritonavir 200 mg/d or 400 mg/d in HIV-infected Patients in Virological Failure.ANRS 104 PUZZLE 1

NCT00196625 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.

NCT NCT00196625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00196625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Safety and Efficacy of Salvage Therapy With Amprenavir, Lopinavir and Ritonavir 200 mg/d or 400 mg/d in HIV-infected Patients in Virological Failure.ANRS 104 PUZZLE 1
Lead sponsor
ANRS, Emerging Infectious Diseases
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2000
Completion date
February 28, 2002
Enrollment
100
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections